Tarsons Products Ltd
TARSONSTarsons Products Ltd
TARSONS
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 38.73 | 3.42 | 0.51% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 49.70 | 6.31 | 0.52% |
Forecast & Ratings
Detailed Forecast from 4 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Tarsons Products Limited is engaged in the designing, development, manufacturing of a range of labware products which helps scientific discovery and healthcare
Investor Presentation
View olderPeers
Compare with peersPoly Medicure Ltd
Borosil Scientific Ltd
Balaxi Pharmaceuticals Ltd
Universus Photo Imagings Ltd
Constronics Infra Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2024 | TTM | ||
|---|---|---|---|---|
| Total Revenue | 307.87 | 391.99 | ||
Raw Materials | 79.27 | 256.05 | ||
| Power & Fuel Cost | 10.88 | |||
| Employee Cost | 44.27 | |||
| Selling & Administrative Expenses | 26.44 | |||
| Operating & Other expenses | 35.69 | |||
EBITDA | 111.32 | 135.94 | ||
| Depreciation/Amortization | 40.40 | 44.63 | ||
| PBIT | 70.92 | 91.31 | ||
| Interest & Other Items | 10.15 | 13.86 | ||
| PBT | 60.77 | 77.45 | ||
| Taxes & Other Items | 18.13 | 23.37 | ||
| Net Income | 42.64 | 54.08 | ||
| EPS | 8.01 | 10.16 | ||
| DPS | 2.00 | 2.00 | ||
| Payout ratio | 0.25 | 0.20 |
Company Updates
Investor Presentation
Peers & Comparison
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Tarsons Products Ltd | 49.12 | 3.42 | 0.51% |
| Poly Medicure Ltd | 102.30 | 17.97 | 0.11% |
| Borosil Scientific Ltd | 68.74 | 4.30 | — |
| Balaxi Pharmaceuticals Ltd | -181.57 | 2.16 | — |
Price Comparison
Compare TARSONS with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 4 Mutual Funds holding Tarsons Products Ltd
| Funds (Top 4) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Bandhan BSE Healthcare Index Fund Direct Plan-Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0004% | Percentage of the fund’s portfolio invested in the stock 0.05% | Change in the portfolio weight of the stock over the last 3 months 0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 95/102 (+2) |
Bandhan Nifty Total Market Index Fund - Direct Plan - Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0000% | Percentage of the fund’s portfolio invested in the stock 0.00% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 756/803 (-6) |
Groww Nifty Total Market Index Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0000% | Percentage of the fund’s portfolio invested in the stock 0.00% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 152/801 (0) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2024
Dividend/Share
₹2.00
Ex DateEx Date
Sep 20, 2024
Net profit of Tarsons Products rose 1.02% to Rs 12.93 crore in the quarter ended September 2024 as against Rs 12.80 crore during the previous quarter ended September 2023. Sales rose 20.81% to Rs 80.12 crore in the quarter ended September 2024 as against Rs 66.32 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales80.1266.32 21 OPM %29.3438.27 - PBDT29.4827.03 9 PBT17.5217.32 1 NP12.9312.80 1 Powered by Capital Market - Live
Tarsons Products will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live
Tarsons Products announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
Net profit of Tarsons Products declined 32.71% to Rs 6.46 crore in the quarter ended June 2024 as against Rs 9.60 crore during the previous quarter ended June 2023. Sales rose 3.64% to Rs 64.85 crore in the quarter ended June 2024 as against Rs 62.57 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales64.8562.57 4 OPM %26.2334.04 - PBDT17.6721.15 -16 PBT8.7112.85 -32 NP6.469.60 -33 Powered by Capital Market - Live
Tarsons Products will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live
Buy Tarsons Products Ltd; target of Rs 770: LKP Research
Tarsons Products slides after Q3 PAT drops 25% YoY to Rs 16 cr
Tarsons Products - Expects The Demand Scenario In Both Domestic, Export Markets To Remain Strong: Nirmal Bang
Nykaa, Paytm, Policy Bazaar: Lock-in periods of 10 IPOs to expire in November
Tarsons Products tumbles after weak Q2 performance
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant